# MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

Study · id `cardio:ct-nct05908331` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05908331](<https://clinicaltrials.gov/study/NCT05908331>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05908331

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 492 participants.

## Technical summary

Registry record NCT05908331. Randomized; double masking; primary purpose treatment. Start 2024-04-16 (actual); primary completion 2025-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 492 participants (planned count; ClinicalTrials.gov record NCT05908331, source copy `cardio:ctgov-nct05908331-2025-02-25`, retrieved 2026-10-26)
- Started: 2024-04-16 (actual) (ClinicalTrials.gov record NCT05908331, source copy `cardio:ctgov-nct05908331-2025-02-25`, retrieved 2026-10-26)
- Primary completion: 2025-09 (anticipated) (ClinicalTrials.gov record NCT05908331, source copy `cardio:ctgov-nct05908331-2025-02-25`, retrieved 2026-10-26)
- Completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT05908331, source copy `cardio:ctgov-nct05908331-2025-02-25`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05908331, source copy `cardio:ctgov-nct05908331-2025-02-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05908331-2025-02-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- Acronym: MAGICAL ISR
- Condition: In-Stent Restenosis
- Condition: Cardiovascular Diseases
- Condition: Coronary Artery Disease
- Intervention (Device): Sirolimus Drug Coated Balloon
- Intervention (Device): Plan balloon Angioplasty (POBA)
- Lead sponsor: Concept Medical Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Cardiovascular Research Foundation, New York
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Concept Medical Inc. (`cardio:org-concept-medical-inc`)
- Registry lists this organization as a collaborator: Cardiovascular Research Foundation, New York (`cardio:org-cardiovascular-research-foundation-new-york`)

## Provenance

Content hash: 9858eeec763a4485252f8f60c17c68b78ee16846305ae97cff6fc1a4d421d11c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
